Bethesda, MD, United States of America

Jenny Heidbrink

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 72(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jenny Heidbrink: Innovator in Breast Disease Detection

Introduction

Jenny Heidbrink is a notable inventor based in Bethesda, MD (US). She has made significant contributions to the field of medical diagnostics, particularly in the detection and treatment of breast diseases. Her innovative work has the potential to improve patient outcomes and advance the understanding of breast-related health issues.

Latest Patents

Jenny Heidbrink holds a patent titled "Breast disease targets and uses thereof." This invention provides a method for diagnosing and detecting diseases associated with the breast. It introduces one or more proteins or fragments, peptides, or nucleic acid molecules that are differentially expressed in breast diseases (BCAT). The invention also includes antibodies that bind to BCAT, which can be used as targets for screening agents that modulate BCAT activities. Furthermore, it outlines methods for treating diseases associated with the breast.

Career Highlights

Heidbrink is currently associated with Celera Corporation, where she continues to work on innovative solutions in the medical field. Her dedication to research and development has positioned her as a key figure in her area of expertise.

Collaborations

Throughout her career, Jenny has collaborated with notable colleagues, including Steve Ruben and Charles E. Birse. These partnerships have contributed to her success and the advancement of her inventions.

Conclusion

Jenny Heidbrink's work in breast disease detection exemplifies the impact of innovation in healthcare. Her contributions are paving the way for new diagnostic methods and treatments that can significantly benefit patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…